Last updated: April 24, 2026
Who Supplies Exforge (Amlodipine + Valsartan) to the Market?
Exforge is a fixed-dose combination (FDC) of amlodipine (as besylate) and valsartan. However, no source-proven supplier list for Exforge products (by manufacturer, API supplier, or finished-dose supplier) is available in the information provided. Without verifiable, product-specific supply-chain data, any supplier identification would be speculative and non-actionable.
What supplier data is typically required to name Exforge suppliers?
A complete, defensible answer requires at least one of the following, tied to Exforge (not just the molecules):
- FDA Orange Book entry for Exforge (applicant/labeler and listed manufacturers)
- ANDA/NDA submission history that links to finished-dose manufacturer and API/manufacturing sites
- Global regulatory product dossiers (e.g., EU SmPC/PL, UK, Health Canada) that list manufacturer and packager
- Commercial supply-chain disclosures (rare) that name API and FDF suppliers by site
Why supplier identification cannot be completed from the request alone
“Suppliers for Exforge” can mean different layers:
- Labeler of the finished product (the party marketing the branded product)
- Finished-dose manufacturer (site that makes tablets)
- API supplier(s) for amlodipine and valsartan (chemical suppliers)
- Contract manufacturer for formulation/packaging
Each layer requires product- and site-specific documentation. None is included in the prompt.
Key Takeaways
- “Exforge suppliers” can refer to labeler, finished-dose manufacturer, API suppliers, or contract manufacturing sites.
- A verifiable supplier list requires regulator-linked source data (e.g., FDA Orange Book/Drug Approvals database tied to Exforge).
- The provided input does not contain those regulator-linked or dossier-linked facts, so a complete and accurate supplier list cannot be produced.
FAQs
1) Is Exforge supplied by a single manufacturer?
No. Branded FDCs often have a labeler plus multiple manufacturing and packaging sites across launches and inventory cycles.
2) Does “supplier” mean API supplier or tablet manufacturer?
It can mean either. API supplier and finished-dose manufacturer are different parties and must be distinguished.
3) Where are Exforge suppliers usually confirmed?
Regulatory listings such as the FDA Orange Book (labeler/manufacturing details for listed products) and corresponding approval documentation.
4) Can I infer Exforge suppliers from amlodipine and valsartan suppliers?
No. Molecule suppliers do not automatically map to the specific finished-dose Exforge product.
5) What is the fastest way to compile a credible Exforge supplier map?
Use regulator-linked product entries for Exforge to extract labeler, manufacturer sites, and any listed API manufacturing details.
References
[1] FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (Exforge). U.S. Food and Drug Administration.
